Related Experiment Video
Updated: Mar 13, 2026
08:45
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
14.3K
Cerenkov luminescence imaging (CLI) for image-guided cancer surgery.
M R Grootendorst1, M Cariati1, A Kothari2
1Department of Research Oncology, 3rd Floor Bermondsey Wing, King's College London, London, SE1 9RT UK ; Department of Breast Surgery, 3rd Floor Tower Wing, Guy's Hospital, London, SE1 9RT UK.
Clinical and Translational Imaging
|October 15, 2016
Summary
Cerenkov luminescence imaging (CLI) uses novel optical detection for image-guided cancer surgery. This technique enhances tumor resection accuracy, potentially improving patient outcomes.
Area of Science:
- Medical Imaging
- Oncology
- Biophysics
Background:
- Cerenkov luminescence imaging (CLI) is an emerging molecular optical imaging technique.
- It detects optical Cerenkov photons emitted by positron emission tomography (PET) imaging agents.
- CLI leverages clinically approved, tumor-targeted tracers and compact imaging devices.
Approach:
- This article reviews the fundamental principles of Cerenkov radiation.
- It discusses challenges and applications of CLI in image-guided cancer surgery.
- The review examines preclinical and clinical trial literature, highlighting ongoing developments.
Key Points:
- CLI enables image-guided cancer surgery by detecting Cerenkov photons from PET tracers.
- Applications include image-guided lymph node detection and Cerenkov luminescence endoscopy.
- Ongoing clinical trials and technological advancements are progressing rapidly.
Conclusions:
- CLI has the potential to significantly improve surgical accuracy and patient outcomes in oncology.
- It offers enhanced oncological and cosmetic results through more complete tumor resections.
- The technique is poised to transform current surgical practices.
